LAWRENCEVILLE, N.J., Dec. 19, 2016 -- 1WorldSync, the leading multi-enterprise product information network, has partnered with Globizz, a market-leading FDA solution provider. The partnership gives enhanced access to UDI database registration and FDA compliance solutions for Japanese healthcare companies seeking to export products to the U.S. market.
|
|||
1WorldSync is the only certified GDSN data pool operating in Japan equipped to help customers meet UDI requirements in the local language. The partnership allows Globizz customers to leverage 1WorldSync’s deep experience in UDI compliance within the medical device market and provides additional consulting services for Japanese healthcare companies expanding to the U.S.
“With the highly regulated nature of the medical device market, businesses require advanced support to meet the product information requirements necessary to sell their products across borders,” said Dan Wilkinson, Chief Commercial Officer of 1WorldSync. “Our dedicated staff of UDI database registration experts in Japan, in tandem with Globizz’s FDA compliance solutions, will provide Japanese companies the support and expertise to scale and distribute product information that complies with today’s regulations.”
Compliance with FDA regulations for the medical device industry requires barcodes to be placed on the device label/packaging and device data elements to be submitted to the FDA’s Global UDI Database (GUDID). Globizz partnered with 1WorldSync, a world leader in the product data industry, for its recognition as a qualified UDI issuing agency by the FDA. This partnership enables easier data management and global expansion while eliminating the language barriers Japanese healthcare companies encounter while seeking to export products into the U.S. market.
“This partnership will allow Globizz to continue to offer the highest quality consulting services in a timely manner, support client’s barcode needs and help expand businesses in both the U.S. and Japan,” said Takahiro Harry Haruyama, President and CEO of Globizz. “As partners, Globizz and 1WorldSync will assist in the full compliance of UDI requirements for the Japanese medical device industry, which is an important element to their success in the U.S.”
For more information, visit www.1worldsync.com.
About 1WorldSync
1WorldSync is the leading multi-enterprise product information network, helping more than 25,000 global brands and their trading partners in over 60 countries – share authentic, trusted content in the hands of their customers and consumers, empowering consumers to make the right choices, purchases, health and lifestyle decisions. Through its solutions, technology platform and expert services, 1WorldSync provides solutions that meet the diverse needs of its customers. For more information, please visit http://www.1worldsync.com
About Globizz
Based in California, Globizz is an international consulting company with extensive experience in cross-border business. Globizz provides FDA consulting services for medical devices, medical drugs, foods, supplements, cosmetics, animal feeds and other biotech products.
Globizz specializes in advising on overseas expansion plans for top-level management businesses and financial planning, as well as market research, overseas base auditing, and cross border M&A advisory between the U.S. and Japan. It also provides on-site personnel training and seminars, and directors for overseas entities. For more information, please visit www.globizz.net.
Media Contact Rachel Gulden [email protected] 312-267-0530


SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains 



